|
|
Volumn 214, Issue 1-2, 2001, Pages 83-85
|
|
A new approach for targeting to Cryptosporidium parvum using mucoadhesive nanosuspensions: Research and applications
|
|
Author keywords
Bioadhesion; Bupravaquone; Chitosan; Cryptosporidium; Drug delivery; HIV; In vitro; In vivo; Mucoadhesion; Nanosuspension
|
|
Indexed keywords
ANTIBIOTIC AGENT;
BUPRAVAQUONE;
CHITOSAN;
KETONE DERIVATIVE;
NANOPARTICLE;
POLYMER;
UNCLASSIFIED DRUG;
ANIMAL EXPERIMENT;
ANIMAL MODEL;
ANIMAL TISSUE;
CONFERENCE PAPER;
CONTROLLED STUDY;
CRYPTOSPORIDIOSIS;
CRYPTOSPORIDIUM PARVUM;
DIARRHEA;
DRUG ACTIVITY;
DRUG BIOAVAILABILITY;
DRUG DELIVERY SYSTEM;
DRUG EFFECT;
DRUG EFFICACY;
DRUG ELIMINATION;
DRUG MECHANISM;
DRUG RETENTION;
DRUG SOLUBILITY;
DRUG STRUCTURE;
GASTROINTESTINAL INFECTION;
GASTROINTESTINAL TRACT;
HYDROGEL;
MOUSE;
NONHUMAN;
PATHOPHYSIOLOGY;
PRIORITY JOURNAL;
SUSPENSION;
ANIMALS;
ANTIPROTOZOAL AGENTS;
CHITIN;
CHITOSAN;
CRYPTOSPORIDIUM PARVUM;
DRUG DELIVERY SYSTEMS;
MICE;
SUSPENSIONS;
|
|
EID: 0035910888
PISSN: 03785173
EISSN: None
Source Type: Journal
DOI: 10.1016/S0378-5173(00)00640-2 Document Type: Conference Paper |
|
Times cited : (68)
|
|
References (10)
|
